CCA - Cancer biology and immunology (VUmc)

Research output

Research output per year 1979 2017 2018 2019 2020 2021 2022 2023 2024

• 3529 Article
• 473 Review article
• 195 Meeting Abstract
• 152 Comment/Letter to the editor
• 423 More
  • 116 Chapter
  • 83 Letter
  • 78 Phd-Thesis - Research and graduation internal
  • 59 Editorial
  • 25 Erratum/Corrigendum
  • 17 Conference contribution
  • 10 Short survey
  • 8 Report
  • 6 Abstract
  • 4 Book
  • 4 Paper
  • 4 Phd-Thesis - Research and graduation external
  • 3 Poster
  • 2 Inaugural speech
  • 1 Book editing
  • 1 Digital or Visual Products
  • 1 Software
  • 1 Patent

Research output per year

Research output per year

Search results

• 2024

  Brushing beyond biopsies: using the full potential of bile duct brushes

  Fritzsche, J. A., Ponsioen, C. Y., Verheij, J. & Voermans, R. P., 1 Mar 2024, In: Gastrointestinal Endoscopy. 99, 3, p. 477-478

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  1 Citation (Scopus)

• Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab

  Laheij, A. M. G. A. & van de Donk, N. W. C. J., 1 Jan 2024, In: Supportive Care in Cancer. 32, 1, 20.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Controversies in upper GI oncology: MSI-H in gastroesophageal adenocarcinoma

  Petrillo, A., Derks, S. & Smyth, E. C., 1 Feb 2024, In: ESMO open. 9, 2, 102229.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome Medicine, (2023), 15, 1, (22), 10.1186/s13073-023-01173-8)

  COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC Covid-19 Biobank, NIAID-USUHS COVID Study Group & COVID Human Genetic Effort, Dec 2024, In: Genome Medicine. 16, 1, 6.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Pembrolizumab plus chemotherapy for advanced gastric cancer

  Schutte, T., Derks, S. & van Laarhoven, H. W. M., 1 Feb 2024, In: The Lancet Oncology. 25, 2, p. e51

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Response to Letter RE: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study

  Debets, P., Dreijerink, K. M. A., Engelsman, A., Dahele, M., Haak, H. R., Steenaard, R. V., Kapiteijn, E., Corssmit, E. & Menke – van der Houven van Oordt, W., 1 May 2024, In: European Journal of Cancer. 202, p. 114035 114035.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Severe multiple therapy refractory colitis in a 46-year-old man

  Carpay, N., de Boer, N. K. H., Neefjes-Borst, A. & Bots, S., 2024, (E-pub ahead of print) In: Gut. gutjnl-2024-331934.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Sub-lobar resections for peripheral non-small cell lung cancer measuring ≤ 2 cm: Insights from recent clinical trials

  Senan, S., Schneiders, F. L. & Moghanaki, D., Mar 2024, In: Radiotherapy and oncology. 192, p. 110094 110094.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands

  Pennings, E. R. A., Durmaz, M. J., Visser, O., Posthuma, E. F. M., Issa, D. E., Chamuleau, M. E. D., Lugtenburg, P. J., Kersten, M. J. & Dinmohamed, A. G., 1 Dec 2024, In: Blood Cancer Journal. 14, 1, 3.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2023

  A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease

  Mato Prado, M., Puik, J. R., Castellano, L., López-Jiménez, E., Liu, D. S. K., Meijer, L. L., le Large, T. Y. S., Rees, E., Funel, N., Sivakumar, S., Pereira, S. P., Kazemier, G., Zonderhuis, B. M., Erdmann, J. I., Swijnenburg, R-J., Frilling, A., Jiao, L. R., Stebbing, J., Giovannetti, E., Krell, J., & 1 othersFrampton, A. E., 1 Dec 2023, In: Experimental hematology & oncology. 12, 1, 101.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: Head and neck squamous cell carcinoma (Nature Reviews Disease Primers, (2020), 6, 1, (92), 10.1038/s41572-020-00224-3)

  Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E. & Grandis, J. R., 1 Dec 2023, In: NATURE REVIEWS DISEASE PRIMERS. 9, 1, 4.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  6 Citations (Scopus)

• Claudin-18.2 targeting by zolbetuximab: results of SPOTLIGHT in perspective

  van Laarhoven, H. W. M. & Derks, S., 20 May 2023, In: The Lancet. 401, 10389, p. 1630-1631 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  4 Citations (Scopus)

• Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

  Zeidan, A. M., Platzbecker, U., Bewersdorf, J. P., Stahl, M., Adès, L., Borate, U., Bowen, D., Buckstein, R., Brunner, A., Carraway, H. E., Daver, N., Díez-Campelo, M., de Witte, T., DeZern, A. E., Efficace, F., Garcia-Manero, G., Garcia, J. S., Germing, U., Giagounidis, A., Griffiths, E. A., & 16 othersHasserjian, R. P., Hellström-Lindberg, E., Iastrebner, M., Komrokji, R., Kulasekararaj, A. G., Malcovati, L., Miyazaki, Y., Odenike, O., Santini, V., Sanz, G., Scheinberg, P., Stauder, R., van de Loosdrecht, A. A., Wei, A. H., Sekeres, M. A. & Fenaux, P., 27 Apr 2023, In: Blood. 141, 17, p. 2047-2061 15 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  30 Citations (Scopus)

• Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

  Dutch Pancreatic Cancer Group, 1 Dec 2023, In: BMC Cancer. 23, 1, 70.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

  the International Agency for Research on Cancer/World Health Organization, Sept 2023, In: Leukemia. 37, 9, p. 1944-1951 8 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial (Surgical Endoscopy, (2023), 37, 9, (7317-7324), 10.1007/s00464-023-10278-5)

  van der Wielen, N., Daams, F., Rosati, R., Parise, P., Weitz, J. R., Reissfelder, C., del Val, I. D., Loureiro, C., Parada-González, P., Pintos-Martínez, E., Vallejo, F. M., Achirica, C. M., Sánchez-Pernaute, A., Campos, A. R., Bonavina, L., Asti, E. L. G., Poza, A. A., Gilsanz, C., Nilsson, M., Lindblad, M., & 8 othersGisbertz, S. S., van Berge Henegouwen, M. I., Romario, U. F., de Pascale, S., Akhtar, K., Cuesta, M. A., van der Peet, D. L. & Straatman, J., 1 Sept 2023, In: Surgical endoscopy. 37, 9, p. 7393-7394 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Correction: Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial) (Cancers, (2020), 12, (3745), 10.3390/cancers12123745)

  van de Velde, M. E., Kaspers, G. J. L., Abbink, F. C. H., Twisk, J. W. R., van der Sluis, I. M., van den Bos, C., van den Heuvel-Eibrink, M. M., Segers, H., Chantrain, C., van der Werff ten Bosch, J., Willems, L. & van den Berg, M. H., 1 Mar 2023, In: Cancers. 15, 5, 1359.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x)

  Song, D., Cismas, S., Crudden, C., Trocme, E., Worrall, C., Suleymanova, N., Lin, T., Zheng, H., Seregard, S., Girnita, A. & Girnita, L., 10 Mar 2023, In: Oncogene. 42, 11, p. 858 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology (Virchows Archiv, (2023), 10.1007/s00428-023-03579-6)

  Rodriguez-Pinilla, S. M., Dojcinov, S., Dotlic, S., Gibson, S. E., Hartmann, S., Klimkowska, M., Sabattini, E., Tousseyn, T. A., de Jong, D. & Hsi, E. D., 2023, (E-pub ahead of print) In: Virchows Archiv.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up (Journal of Neuro-Oncology, (2023), 161, 2, (357-370), 10.1007/s11060-022-04223-0)

  the Dutch Meningioma Consortium, Jan 2023, In: Journal of Neuro-Oncology. 161, 2, p. 371 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site (British Journal of Cancer, (2021), 124, 4, (777-785), 10.1038/s41416-020-01153-4)

  RAIDs Consortium, 18 May 2023, In: British journal of cancer. 128, 9, p. 1790 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification (Acta Neuropathologica, (2023), 145, 1, (49-69), 10.1007/s00401-022-02516-2)

  Keck, M-K., Sill, M., Wittmann, A., Joshi, P., Stichel, D., Beck, P., Okonechnikow, K., Sievers, P., Wefers, A. K., Roncaroli, F., Avula, S., McCabe, M. G., Hayden, J. T., Wesseling, P., Øra, I., Nistér, M., Kranendonk, M. E. G., Tops, B. B. J., Zapotocky, M., Zamecnik, J., & 36 othersVasiljevic, A., Fenouil, T., Meyronet, D., von Hoff, K., Schüller, U., Loiseau, H., Figarella-Branger, D., Kramm, C. M., Sturm, D., Scheie, D., Rauramaa, T., Pesola, J., Gojo, J., Haberler, C., Brandner, S., Jacques, T., Sexton Oates, A., Saffery, R., Koscielniak, E., Baker, S. J., Yip, S., Snuderl, M., Ud Din, N., Samuel, D., Schramm, K., Blattner-Johnson, M., Selt, F., Ecker, J., Milde, T., von Deimling, A., Korshunov, A., Perry, A., Pfister, S. M., Sahm, F., Solomon, D. A. & Jones, D. T. W., Apr 2023, In: Acta Neuropathologica. 145, 4, p. 511-514 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Detecting KRAS mutations in pancreatic cystic neoplasms: droplet digital PCR versus targeted next-generation sequencing

  van Huijgevoort, N. C. M., Halfwerk, H. B. G., Lekkerkerker, S. J., Reinten, R. J., Ramp, F., Fockens, P., Besselink, M. G., Busch, O. R., van Noesel, C. J. M., van de Vijver, M. J., Verheij, J., van Hooft, J. E. & Dijk, F., 1 Jan 2023, In: HPB: The official journal of the International Hepato Pancreato Biliary Association. 25, 1, p. 155-159 5 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• DNA Methylation Testing for Endometrial Cancer Detection in Urine, Cervicovaginal Self-Samples and Cervical Scrapes

  Wever, B. M. M., van den Helder, R., van Splunter, A. P., van Gent, M. D. J. M., Kasius, J. C., Trum, J. W., Verhoeve, H. R., van Baal, W. M., Hulbert, A., Verhoef, L., Heideman, D. A. M., Lissenberg-Witte, B. I., van Trommel, N. E., Steenbergen, R. D. M. & Bleeker, M. C. G., 1 Oct 2023, In: Obstetrical and Gynecological Survey. 78, 10, p. 581-582 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Erratum to “Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue” [Eur J Surg Oncol 49 (5) (May 2023) 974–982](S074879832300032X)(10.1016/j.ejso.2023.01.010)

  the TENTACLE – Esophagus collaborative group, 1 Sept 2023, In: European Journal of Surgical Oncology. 49, 9, 106993.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• hENT1 as a Predictive Biomarker in PDAC—Letter

  Boyd, L. N. C., Ali, M., Puik, J. R., Meijer, L. L., le Large, T. Y. S., van Laarhoven, H. W. M., Giovannetti, E. & Kazemier, G., 1 Aug 2023, In: Clinical Cancer Research. 29, 15, p. 2944 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042

  Maas, S. L. N., Sievers, P., Weber, D. C., Weller, M., van den Bent, M. J., Mair, M. J., Kros, J. M., Carparrotti, F., von Deimling, A., Salvador, V. F., Peerdeman, S. M., Casas-Martin, J., Gorlia, T., Sahm, F. & Preusser, M., Dec 2023, In: Acta Neuropathologica. 146, 6, p. 837-840 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  2 Citations (Scopus)

• Minimally invasive oesophagectomy as standard of care

  Noordman, B. J. & Gisbertz, S. S., 1 Sept 2023, In: The British journal of surgery. 110, 9, p. 1118-1119 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes

  Brunner, A. M., Esteve, J., Porkka, K., Knapper, S., Traer, E., Scholl, S., Garcia-Manero, G., Vey, N., Wermke, M., Janssen, J. J. W. M., Narayan, R., Fleming, S., Loo, S., Tovar, N., Kontro, M., Ottmann, O. G., Naidu, P., Sun, H., Han, M., White, R., & 7 othersZhang, N., Mohammed, A., Sabatos-Peyton, C. A., Steensma, D. P., Rinne, M. L., Borate, U. M. & Wei, A. H., 2023, (E-pub ahead of print) In: American journal of hematology.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Replay to the Comment on Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis

  Polak, T. B., Janssen, J. J. W. M. & Cucchi, D. G. J., 1 Mar 2023, In: Haematologica. 108, 3, p. 928 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• SPOTlight on GLOW

  Derks, S. & van Laarhoven, H. W. M., 17 Oct 2023, In: Cell Reports Medicine. 4, 10, 101233.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma

  van Laarhoven, H. W. M. & Derks, S., 18 Apr 2023, In: Cell Reports Medicine. 4, 4, 100990.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population

  Kockerols, C. C. B., Janssen, J. J. W. M., Blijlevens, N. M. A., Klein, S. K., van Hussen-Daenen, L. G. M., van Gorkom, G. G. Y., Smit, W. M., van Balen, P., Biemond, B. J., Cruijsen, M. J., Corsten, M. F., te Boekhorst, P. A. W., Koene, H. R., van Sluis, G. L., Cornelissen, J. J. & Westerweel, P. E., 1 Jan 2023, In: Haematologica. 108, 1, p. 240-244 5 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  3 Citations (Scopus)
• 2022

  A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma

  Mendeville, M., Janssen, J., Kim, Y., van Dijk, E., de Jong, D. & Ylstra, B., Sept 2022, In: Leukemia. 36, 9, p. 2177-2179 3 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  4 Citations (Scopus)

• Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial

  the Amsterdam UMC COVID-19 Biobank Investigators, 1 Dec 2022, In: Respiratory research. 23, 1, 6 p., 375.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  7 Citations (Scopus)

• Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis

  Polak, T. B., van Rosmalen, J., Dirven, S., Herzig, J. K., Cloos, J., Meshinchi, S., Döhner, K., Janssen, J. J. W. M. & Cucchi, D. G. J., 1 Oct 2022, In: Haematologica. 107, 10, p. 2506-2510 5 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  5 Citations (Scopus)

• Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood (Nature Communications, (2021), 12, 1, (7104), 10.1038/s41467-021-27326-0)

  UK National PAH Cohort Study Consortium, Dec 2022, In: Nature communications. 13, 1, 7276.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment

  Drees, E. E. E., Jauw, Y. W. S., van Dijk, E., Borchmann, S., Verkuijlen, S. A. W. M., Stathi, P., Groenewegen, N. J., Hijmering, N. J., Berry, D. R. A. I., Meershoek, E. J., Hoogmoed, D., Kwakman, A., Molenaar, T. J., Pegtel, D. M., Ylstra, B., de Jong, D., Zijlstra, J. M. & Roemer, M. G. M., 4 Jul 2022, In: HemaSphere. 6, 7, p. E749

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (Breast Cancer Research, (2022), 24, 1, (69), 10.1186/s13058-022-01567-3)

  Giardiello, D., Hooning, M. J., Hauptmann, M., Keeman, R., Heemskerk-Gerritsen, B. A. M., Becher, H., Blomqvist, C., Bojesen, S. E., Bolla, M. K., Camp, N. J., Czene, K., Devilee, P., Eccles, D. M., Fasching, P. A., Figueroa, J. D., Flyger, H., García-Closas, M., Haiman, C. A., Hamann, U., Hopper, J. L., & 19 othersJakubowska, A., Leeuwen, F. E., Lindblom, A., Lubiński, J., Margolin, S., Martinez, M. E., Nevanlinna, H., Nevelsteen, I., Pelders, S., Pharoah, P. D. P., Siesling, S., Southey, M. C., van der Hout, A. H., van Hest, L. P., Chang-Claude, J., Hall, P., Easton, D. F., Steyerberg, E. W. & Schmidt, M. K., 1 Dec 2022, In: Breast Cancer Research. 24, 1, 82.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis (British Journal of Cancer, (2021), 124, 7, (1222-1230), 10.1038/s41416-020-01229-1)

  van Breeschoten, J., Wouters, M. W. J. M., Hilarius, D. L., Haanen, J. B., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J-W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Blokx, W. A. M., Tije, B-J. J. T., Veldt, A. A. M. V. D., Vreugdenhil, A., Boers-Sonderen, M. J. & van den Eertwegh, A. J. M., 18 May 2022, In: British journal of cancer. 126, 9, p. 1362 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia (Advances in Therapy, (2022), 39, 4, (1474-1488), 10.1007/s12325-021-01948-8)

  Santini, V., Lübbert, M., Wierzbowska, A. & Ossenkoppele, G. J., Apr 2022, In: Advances in therapy. 39, 4, p. 1489 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Correction to: Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin‑based HIPEC: results of the GUTOX study (Cancer Chemotherapy and Pharmacology, (2020), 86, 1, (141-150), 10.1007/s00280-020-04107-y)

  de Jong, L. A. W., Elekonawo, F. M. K., Lambert, M., de Gooyer, J. M., Verheul, H. M. W., Burger, D. M., de Wilt, J. H. W., Chatelut, E., ter Heine, R., de Reuver, P. R., Bremers, A. J. A. & van Erp, N. P., Aug 2022, In: Cancer Chemotherapy and Pharmacology. 90, 2, p. 189-190 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: Diagnosis of atypical carcinoid can be made on biopsies > 4 mm² and is accurate (Virchows Archiv, (2022), 480, 3, (587-593), 10.1007/s00428-022-03279-7)

  Reuling, E. M. B. P., Naves, D. D., Daniels, J. M. A., Dickhoff, C., Kortman, P. C., Broeckaert, M. A. M. B., Plaisier, P. W., Thunnissen, E. & Radonic, T., Mar 2022, In: Virchows Archiv. 480, 3, p. 595 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: Guidelines for magnetic resonance imaging in pediatric head and neck pathologies: a multicentre international consensus paper (Neuroradiology, (2022), 64, 6, (1081-1100), 10.1007/s00234-022-02950-9)

  on behalf of the Consensus for Magnetic Resonance Protocols Study (COMPS) Group, Jun 2022, In: Neuroradiology. 64, 6, p. 1309 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)

  Femel, J., van Hooren, L., Herre, M., Cedervall, J., Saupe, F., Huijbers, E. J. M., Verboogen, D. R. J., Reichel, M., Thijssen, V. L., Griffioen, A. W., Hellman, L., Dimberg, A. & Olsson, A-K., Oct 2022, In: Cancer Immunology, Immunotherapy. 71, 10, p. 2581 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  2 Citations (Scopus)

• Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study (Intensive Care Medicine, (2022), 48, 6, (690-705), 10.1007/s00134-022-06705-1)

  the ESICM UNITE-COVID investigators, 1 Aug 2022, In: Intensive care medicine. 48, 8, p. 1130-1131 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Corrigendum: “Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’”: (Annals of Oncology (2022) 33(1) (117), (S0923753421044999), (10.1016/j.annonc.2021.10.001))

  EHA Guidelines Committee ESMO Guidelines Committee, Sept 2022, In: Annals of Oncology. 33, 9, p. 988 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’: (Annals of Oncology (2021) 32(3) (309–322), (S0923753420431692), (10.1016/j.annonc.2020.11.014))

  EHA Guidelines Committee ESMO Guidelines Committee, 1 Jan 2022, In: Annals of Oncology. 33, 1, p. 117 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  4 Citations (Scopus)

• Designer protein circuits enable safe cancer immunotherapy

  Hamieh, M. & Themeli, M., 30 Jun 2022, In: NATURE. 606, 7916, p. 868-869 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  2 Citations (Scopus)

• Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)

  Waqar, M., Roncaroli, F., Lehrer, E. J., Palmer, J. D., Villanueva-Meyer, J., Braunstein, S., Hall, E., Aznar, M., de Witt Hamer, P. C., D'Urso, P. I., Trifiletti, D., Quiñones-Hinojosa, A., Wesseling, P. & Borst, G. R., 1 Jan 2022, In: Neuro-oncology advances. 4, 1, vdac125.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access